Cross-Sector Coalition Calls for Significantly Increased Investments to Combat AMR
A coalition of organizations representing clinicians, scientists, patients, public health professionals and animal agriculture experts as well as members of the pharmaceutical and diagnostics industries are asking congressional leaders to significantly increase U.S. investments to combat the growing threat of infections resistant to existing antibiotics, and build arsenals of new infection-fighting drugs.
More than 50 organizations signed on to letters to House and Senate chairs and ranking members of subcommittees that set funding for the Departments of Health and Human Services, Agriculture, State and Defense, describing the toll of antimicrobial resistance. At least 35,000 lives in the United States and 700,000 lives globally are lost each year to infections that can’t be treated with available medicines. Drug-resistant infections, which sicken at least 28 million people in the U.S. each year, add at least $20 billion to American health care costs, the letters note, and as much as $1.2 billion globally. Modern medical advances that include cancer chemotherapy, transplantation, cesarian sections and other surgeries rely upon the availability of safe and effective antibiotics.
The COVID-19 pandemic, leading to high levels of antibiotic use as well as increased exposure to resistant infections among hospitalized patients severely ill from the coronavirus, also has highlighted the critical importance of controlling antibiotic resistance and developing new antibiotics to be better prepared for future health threats.
Global Ambassador Network
Welcome at the AMR Insights Ambassador Network!
The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).